1. Beyond cholesterol. Modifications of lowdensity lipoprotein that increase its atherogenicity;Steinberg;N Engl J Med,1989
2. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism;Morrow,1990
3. Non-cyclooxygenase-derived prostanoids F2-isopro-stanes) are formed in situ on phospholipids;Morrow,1992
4. Effects of a novel prostaglandin, 8-epiPGF2α, in rabbit lung in situ;Banerjee;Am J Physiol,1992
5. The F2-isoprostane, 8-epi-PGF2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist;Morrow;Prostaglandins,1992